Search results
Found 9477 matches for
Celebrating a major milestone for one of Europe’s biggest type 1 diabetes research cooperations: The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) has successfully screened 100,000 newborns across Europe (including over 7500 newborns in the Thames Valley) for an increased genetic risk of developing type 1 diabetes.
Lydia Coxon
Lydia Coxon - Senior Postdoctoral Research Assistant in Pain Data Collection and Analysis
Kevin Coward
BSC (Hons) PhD (Stirllng) PGDipLATHE (Oxon) SFHEA FRSB CBiol CSciTeach Kevin Coward - Associate Professor, Director of Taught Programmes and Co-Director of the MSc in Reproductive Genetics
Rebecca Dragovic
BSc (Hons) DPhil (oxon) Rebecca Dragovic - Director of the MSc in Clinical Embryology
Arri Coomarasamy
OBE, MBChB, MD, FRCOG, FMedSci Arri Coomarasamy - Professor of Gynaecology and Reproductive Medicine
Uchenna Gwacham-Anisiobi
Uchenna Gwacham-Anisiobi - Deputy Director of the MSc in Global Women's Health
Latest news
Unequal access to early pregnancy scans delays detection of serious conditions
25 November 2025
Early screening resulted in earlier detection for 40% of anomalies, including heart and limb issues. Researchers from the University of Oxford, together with colleagues from the NHS and other partners, have published the first population-level study linking first-trimester ultrasound practice with early detection rates for serious congenital anomalies.
Early Diagnosis Saves Lives: New Study Highlights Critical Window for Postpartum Haemorrhage Care
18 November 2025
A new international study co-led by Professor Arri Coomarasamy of the University of Birmingham and the Nuffield Department of Women’s and Reproductive Health, University of Oxford, has shown that diagnosing postpartum haemorrhage (PPH) within the first 90 minutes after childbirth can be crucial in preventing maternal deaths.
From Oxford to Empowerment: Why Fertility Awareness Matters
14 November 2025
We’re delighted to share an inspiring piece by Maryam Rahbar, a former MSc in Clinical Embryology and DPhil student in Women’s & Reproductive Health at Oxford. Drawing on her academic journey and passion for translating science into empowerment, Maryam explores the science and significance of fertility awareness and preservation. Her reflections remind us that informed choice, grounded in knowledge, not fear, is one of the most powerful forms of reproductive autonomy.
Oxford researchers awarded funding to pioneer ovarian cancer vaccine development
14 November 2025
Ovarian cancer remains a devastating global health challenge: each year, over 300,000 women are diagnosed, and nearly 200,000 lives are lost, largely because the disease is detected at a late stage. Women carrying inherited genetic changes face a significantly elevated lifetime risk, over 40%, and current preventive strategies often require invasive surgery that compromises fertility. These limitations underscore an urgent need for non-surgical preventive options, and vaccines could offer a groundbreaking solution.
Related new stories
Upcoming OxTalks
-
International conference Island and Empire: Revolts, Repressions, Memories From the Mediterranean to the Caribbean (18th–21st Centuries)
Monday, 15 December 2025 to Tuesday, 16 December 2025, 8.30am - 12pm
-
2-Day International conference - 15-16 December: Island and Empire: Revolts, Repressions, Memories From the Mediterranean to the Caribbean (18th–21st Centuries)
Monday, 15 December 2025 to Tuesday, 16 December 2025, 9am - 5pm
-
Research Frontiers in Biodiversity Finance and Policy: A Conversation with Sara Löfqvist
Monday, 15 December 2025, 9.30am to 10.30am